Published in Eur Urol on June 26, 2008
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci Transl Med (2011) 4.51
Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology (2006) 2.63
The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem (2009) 1.61
Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder. BJU Int (2014) 1.57
Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474. Cancer Res (2004) 1.39
Clinical guidelines for overactive bladder. Int J Urol (2009) 1.27
Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat (2006) 1.25
Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure. Biochem Biophys Res Commun (2011) 1.13
Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells. J Am Soc Nephrol (2004) 1.12
Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs. Urology (2008) 1.10
Endovascular treatment of ureteroarterial fistulas with stent-grafts. Radiat Med (2008) 1.08
Transient receptor potential channel A1 involved in sensory transduction of rat urinary bladder through C-fiber pathway. Urology (2007) 1.07
Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J Immunol (2009) 1.05
Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology (2010) 1.05
Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms--ASSIST, randomized controlled study. Urology (2011) 1.01
Rapid, transient induction of ER stress in the liver and kidney after acute exposure to heavy metal: evidence from transgenic sensor mice. FEBS Lett (2007) 0.99
Overexpression of epithelial sodium channels in epithelium of human urinary bladder with outlet obstruction. Urology (2004) 0.98
Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clin Ther (2005) 0.97
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatment. J Thorac Oncol (2012) 0.97
The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis (2003) 0.96
Metastatic uveal tumor secondary to testicular choriocarcinoma. Jpn J Ophthalmol (2004) 0.93
Continuous, noninvasive monitoring of local microscopic inflammation using a genetically engineered cell-based biosensor. Lab Invest (2005) 0.93
Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol (2006) 0.92
Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia. Urology (2010) 0.92
Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer. J Thorac Oncol (2015) 0.92
DRESSA: biosensing of dioxin and dioxin-like chemicals using secreted alkaline phosphatase. Anal Biochem (2004) 0.92
Involvement of hypoxia-triggered endoplasmic reticulum stress in outlet obstruction-induced apoptosis in the urinary bladder. Lab Invest (2008) 0.92
Amiloride-sensitive ion channels in urinary bladder epithelium involved in mechanosensory transduction by modulating stretch-evoked adenosine triphosphate release. Urology (2007) 0.91
Real-time monitoring of mesangial cell-macrophage cross-talk using SEAP in vitro and ex vivo. Kidney Int (2005) 0.89
Synergistic effects of PDGF-BB and cAMP-elevating agents on expression of connexin43 in mesangial cells. Am J Physiol Renal Physiol (2005) 0.89
Selection of autophagy or apoptosis in cells exposed to ER-stress depends on ATF4 expression pattern with or without CHOP expression. Biol Open (2013) 0.88
Roles of mechanosensitive ion channels in bladder sensory transduction and overactive bladder. Int J Urol (2008) 0.88
Sex-related differences in activity of lower urinary tract in response to intravesical acid irritation in decerebrate unanesthetized mice. Am J Physiol Regul Integr Comp Physiol (2008) 0.88
Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells. J Biol Chem (2011) 0.88
Effects of urethane on reflex activity of lower urinary tract in decerebrate unanesthetized rats. Am J Physiol Renal Physiol (2012) 0.87
Treatment of abdominal malignancy invading the vena cava: a report of seven cases. Surg Today (2007) 0.87
Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: a possible involvement in irritative bladder symptoms. BJU Int (2009) 0.87
Relationship of bladder dysfunction to lesion site in multiple sclerosis. J Urol (2003) 0.87
Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system. Br J Pharmacol (2006) 0.87
Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer. Int J Urol (2006) 0.87
Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients. Oncol Rep (2012) 0.85
Current and future directions in diagnostic markers in interstitial cystitis. Int J Urol (2003) 0.84
Functional roles of TRPV1 channels in lower urinary tract irritated by acetic acid: in vivo evaluations of the sex difference in decerebrate unanesthetized mice. Am J Physiol Renal Physiol (2010) 0.84
A novel mass spectrometry-based assay for diagnosis of EML4-ALK-positive non-small cell lung cancer. J Thorac Oncol (2012) 0.84
Prospective study evaluating the plasma concentrations of twenty-six cytokines and response to morphine treatment in cancer patients. Anticancer Res (2011) 0.84
Nonsteroidal anti-inflammatory drug flufenamic acid is a potent activator of AMP-activated protein kinase. J Pharmacol Exp Ther (2011) 0.84
Incontinence and detrusor dysfunction associated with pelvic organ prolapse: clinical value of preoperative urodynamic evaluation. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.84
5'-AMP-activated protein kinase attenuates adriamycin-induced oxidative podocyte injury through thioredoxin-mediated suppression of the apoptosis signal-regulating kinase 1-P38 signaling pathway. Mol Pharmacol (2013) 0.83
Intraperitoneal rupture of giant hydronephrosis due to ureteral cancer accompanied by renal cell carcinoma. J Urol (2002) 0.83
A novel salvage technique that does not require catheter removal for exit-site infection. Perit Dial Int (2002) 0.81
Purinergic control of AMPK activation by ATP released through connexin 43 hemichannels - pivotal roles in hemichannel-mediated cell injury. J Cell Sci (2014) 0.81
Inhibition of c-Jun N-terminal kinase ameliorates apoptosis induced by hydrogen peroxide in the kidney tubule epithelial cells (NRK-52E). Nephron (2002) 0.81
Defining overactive bladder as hypersensitivity. Neurourol Urodyn (2007) 0.81
Self-reversed parallel wire balloon technique for dilating unyielding strictures in native dialysis fistulas. J Vasc Interv Radiol (2002) 0.80
ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer (2006) 0.80
Long-term gefitinib treatment of occult lung carcinoma with multiple brain metastases. Lung Cancer (2012) 0.80
Decreased expression of the epithelial Ca2+ channel TRPV5 and TRPV6 in human renal cell carcinoma associated with vitamin D receptor. J Urol (2011) 0.80
Multifocal metastases of recurrent renal cell carcinoma successfully treated with a combination of low dose interleukin-2, alpha-interferon and radiotherapy. Int J Urol (2005) 0.80
Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor. Cancer Sci (2012) 0.79
β-Catenin signaling contributes to platelet derived growth factor elicited bladder smooth muscle cell contraction through up-regulation of Cx43 expression. J Urol (2012) 0.79
A string pattern regression algorithm and its application to pattern discovery in long introns. Genome Inform (2002) 0.79
Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung. Cancer Chemother Pharmacol (2013) 0.78
Efficiently finding regulatory elements using correlation with gene expression. J Bioinform Comput Biol (2004) 0.78
Suppression of cell membrane permeability by suramin: involvement of its inhibitory actions on connexin 43 hemichannels. Br J Pharmacol (2014) 0.78
Connexin43 hemichannel-mediated regulation of connexin43. PLoS One (2013) 0.78
Prevalence and impact on generic quality of life of urinary incontinence in Japanese working women: assessment by ICI questionnaire and SF-36 Health Survey. Urology (2005) 0.78
Retroperitoneoscopic nephron-sparing surgery of renal tumor using a microwave tissue coagulator without renal ischemia: comparison with open procedure. J Endourol (2003) 0.78
Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors. Invest New Drugs (2010) 0.78
Differential impact of lower urinary tract symptoms on generic and disease-specific quality of life in men and women. Urol Int (2008) 0.78
[Two cases of infants with acute renal failure due to bilateral obstructive ureteral stones associated with rotavirus gastroenteritis]. Nihon Hinyokika Gakkai Zasshi (2010) 0.77
Lower urinary tract symptoms in patients with Niigata Minamata disease: a case-control study 50 years after methyl mercury pollution. Int J Urol (2012) 0.77
[Laparoscopic adrenalectomy for isolated metastasis of adrenal glands]. Nihon Hinyokika Gakkai Zasshi (2012) 0.77
AP-1-independent sensitization to oxidative stress-induced apoptosis by proteasome inhibitors. Biochem Biophys Res Commun (2004) 0.76
Afatinib-refractory brain metastases from EGFR-mutant non-small-cell lung cancer successfully controlled with erlotinib: a case report. Anticancer Drugs (2016) 0.76
Re: Kanai A, et al. mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011. Neurourol urodyn 2012;31:300-308. Neurourol Urodyn (2012) 0.75
Eviprostat activates cAMP signaling pathway and suppresses bladder smooth muscle cell proliferation. Int J Mol Sci (2013) 0.75
Usefulness of dynamic volume scanning with 320-row CT in detecting recanalization of pulmonary arteriovenous fistula after coil embolization. Springerplus (2013) 0.75
Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report. BMC Res Notes (2014) 0.75
[The survey for anti-emetic guideline by using questioner]. Gan To Kagaku Ryoho (2015) 0.75
Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard. Urology (2011) 0.75
Muscarinic receptor binding of the novel radioligand, [3h]imidafenacin in the human bladder and parotid gland. J Pharmacol Sci (2013) 0.75
[Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with metastatic urothelial carcinoma--a case report]. Gan To Kagaku Ryoho (2003) 0.75
Renography as a measure of renal and neobladder function in patients with ileal bladder substitution. Urol Int (2002) 0.75
Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer. Anticancer Res (2013) 0.75
Modified endoscopic live donor nephrectomy: retroperitoneoscopy followed by hand-assistance. Int J Urol (2005) 0.75
[The Japanese version of the National Institutes of Health Chronic Prostatitis Symptom Index]. Nihon Hinyokika Gakkai Zasshi (2014) 0.75
Marked response to both S-1 and pemetrexed in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinoma. Acta Oncol (2012) 0.75
"Urgency tip": a portable patient-activated device for objective measurement of urinary urgency. Urology (2007) 0.75
[Development of the measures to evaluate the similarity of drug brand names]. Yakugaku Zasshi (2006) 0.75
Fesoterodine, its active metabolite, and tolterodine bind selectively to muscarinic receptors in human bladder mucosa and detrusor muscle. Urology (2013) 0.75
Decreased expression of G protein-coupled receptor kinases in the detrusor smooth muscle of human urinary bladder with outlet obstruction. Int J Urol (2006) 0.75
An O(N2) algorithm for discovering optimal Boolean pattern pairs. IEEE/ACM Trans Comput Biol Bioinform (2006) 0.75
Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer. Lung Cancer (2010) 0.75